Highland Capital Management (Tennessee)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.63M	Sell	22,940 -1,608	-7%	-$217K	0.17%	133
2026 Q1	$3.14M	Buy	24,548 +129	+0.5%	+$16.1K	0.17%	138
2025 Q4	$2.98M	Sell	24,419 -276	-1%	-$31.6K	0.15%	139
2025 Q3	$2.47M	Buy	24,695 +954	+4%	+$85.9K	0.12%	161
2025 Q2	$1.97M	Sell	23,741 -1,189	-5%	-$94.9K	0.11%	171
2025 Q1	$2.02M	Sell	24,930 -579	-2%	-$51.8K	0.12%	157
2024 Q4	$2.3M	Buy	25,509 +2,404	+10%	+$233K	0.13%	148
2024 Q3	$2.28M	Buy	+23,105	New	+$2.27M	0.13%	157
2024 Q2	–	Sell	-2,375	Closed	-$225K	–	369
2024 Q1	$225K	Buy	+2,375	New	+$220K	0.01%	323

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Highland Capital Management (Tennessee)'s XBI Position: Q2 2026 in Review

Highland Capital Management (Tennessee) reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 6.6% in Q2 2026, selling an estimated $217K and leaving 22,940 shares worth $3.63M. The position accounts for 0.17% of the portfolio, ranked #133.

Highland Capital Management (Tennessee) first reported a position in XBI in Q1 2024 and has held it in 9 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Highland Capital Management (Tennessee) held 22,940 shares of State Street SPDR S&P Biotech ETF worth $3.63M as of Q2 2026.
Highland Capital Management (Tennessee) sold 1,608 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $217K.
State Street SPDR S&P Biotech ETF made up 0.17% of Highland Capital Management (Tennessee)'s portfolio in Q2 2026, its #133 holding.
Highland Capital Management (Tennessee) first reported a position in State Street SPDR S&P Biotech ETF in Q1 2024 and has held it in 9 quarters since.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q2 2026, filed 21 Jul 2026.